세계의 미생물 검사 시장 : 제품, 기술, 생물 유형, 용도별 - 예측(2025-2030년)

The Microbial Testing Market was valued at USD 4.29 billion in 2024 and is projected to grow to USD 4.91 billion in 2025, with a CAGR of 14.93%, reaching USD 9.90 billion by 2030.

Microbial testing has emerged as a critical tool in ensuring the safety, quality, and efficacy of products across a myriad of industries. With the rising demand for reliable, rapid, and accurate diagnostic solutions, the field of microbial testing is undergoing steady evolution, driven by scientific innovation and stringent regulatory mandates. This report outlines the foundational aspects of modern microbial testing, offering an in-depth look at advancements that have reshaped traditional practices, emerging opportunities, and the challenges that stakeholders face in an increasingly complex market. The rapid pace of technological innovation, combined with heightened awareness regarding public health and environmental safety, has redefined how sectors such as healthcare, pharmaceuticals, food processing, and environmental monitoring approach microbial detection and analysis.

The significance of microbial testing cannot be overstated. In an era where public safety and regulatory compliance intersect with commercial imperatives, establishing robust testing protocols is paramount. Today's landscape is defined by a finer balance between precision and speed, enabling organizations to detect harmful contaminants and pathogens swiftly while maintaining high throughput. The evolving nature of microbial threats and the demand for diversification in testing approaches have compelled industry players to invest in advanced methodologies and innovative tools, thus transforming microbial testing into an indispensable component of modern quality assurance frameworks.

Furthermore, the convergence of biology and technology has fostered a groundbreaking environment where digital solutions and automation are increasingly integrated into traditional testing mechanisms. This evolution not only amplifies efficiency and accuracy but also facilitates scalable testing procedures that can meet the demands of a globalized market. As organizations continue to navigate through these dynamic shifts, understanding the multi-faceted aspects of microbial testing will be essential in keeping pace with industry advances and ensuring resilience in the face of emerging challenges.

Transformative Shifts in the Microbial Testing Landscape

In recent years, the microbial testing landscape has experienced a series of transformative shifts that have redefined the protocols and practices historically used by stakeholders. The infusion of cutting-edge technologies, particularly those that integrate data analytics with rapid processing systems, has streamlined testing procedures, reducing turnaround times significantly. The shift from traditional culture-based methodologies to more sophisticated techniques such as PCR and spectrometry is a testament to the market's agile response to the demands for greater accuracy and efficiency.

Advancements in automation and robotics have also paved the way for labs to handle higher volumes of tests without compromising quality. This is critical, especially in situations where rapid decision-making is essential-such as in clinical diagnostics, food safety, or outbreak investigations. As global regulations tighten and quality standards become more rigorous, many organizations have embraced these innovative solutions to maintain competitiveness and ensure compliance. Moreover, the integration of state-of-the-art biosensors and microarray technologies contributes to early detection capabilities, enabling industries to not only diagnose existing problems but also predict potential threats.

This evolution within the microbial testing domain is further accelerated by the need for sustainable practices. With an increased focus on environmental safety and resource conservation, eco-friendly protocols coupled with efficient waste management in laboratory operations have also become significant focal points. Industry players are continually adapting to these changes by re-aligning their operational strategies, investing in research and development, and leveraging collaborative partnerships with technology providers. This proactive approach is essential for sustaining long-term growth and ensuring the safety of environments ranging from clinical to manufacturing settings.

Overall, these transformative trends underscore an industry in the midst of rapid change-one that is determined to push the boundaries of scientific capability in order to meet modern-day challenges. The integration of advanced technologies, automation, and sustainable practices marks the new normal, providing a competitive edge to those who can adeptly navigate this ever-changing landscape.

Key Segmentation Insights in Microbial Testing

A granular analysis of the microbial testing market reveals a rich tapestry of segmentation driven by factors such as product type, technology, organism type, and application. When considering product segmentation, the market is meticulously studied through two primary categories - instruments and reagents along with consumables. Instruments, characterized by sophisticated diagnostic equipment, stand at the forefront of technological advancement, while reagents and consumables ensure that the testing process maintains its precision through high-quality chemicals and ready-to-use solutions.

From a technological standpoint, the field of microbial testing encompasses an array of modern techniques including biosensors, chromatography, culture-based methods, immunological techniques, microarray technology, PCR technology, and spectrometry. Among these, immunological techniques are further dissected into ELISA kits and lateral flow assays, which reflect the constant push towards more efficient and rapid diagnostic procedures. The evolution of these methodologies enables testing capacities to be both highly sensitive and specific, meeting the emerging complexities of pathogen detection.

The segmentation based on organism type provides a nuanced understanding of the market dynamics across different microbial entities such as bacteria, fungi, parasites, and viruses. Each category represents distinct challenges and requires tailored detection strategies, influencing the choice of testing methods and technologies in diverse settings. Meanwhile, segmentation based on application extends this analysis into various industrial sectors including chemical and material manufacturing, clinical diagnostics, environmental monitoring, food testing, and pharmaceutical production. In the clinical realm, deeper insights are derived from assessments targeting bloodstream infections, gastrointestinal diseases, periodontal conditions, respiratory illnesses, sexually transmitted diseases, and urinary tract infections, highlighting the intricate interplay between technology and patient care. Similarly, environmental applications are further delineated by parameters such as soil contamination assessment and water quality testing, while food testing segments extend to beverages, dairy products, fruits and vegetables, poultry and meat, and seafood. Each of these categories demands rigorous testing protocols that not only ensure safety but also adhere to stringent regulatory standards across diverse markets.

This comprehensive segmentation analysis offers valuable insights into how the market is partitioned and allows stakeholders to align their strategies in accordance with specific requirements and technological innovations. Recognizing these diverse segments provides clarity on where investments are most urgently needed, ultimately driving more focused research and development efforts in tailored diagnostic solutions.

Based on Product, market is studied across Instruments and Reagents & Consumables.

Based on Technology, market is studied across Biosensors, Chromatography, Culture-Based Methods, Immunological Techniques, Microarray Technology, PCR Technology, and Spectrometry. The Immunological Techniques is further studied across ELISA Kits and Lateral Flow Assays.

Based on Organism Type, market is studied across Bacteria, Fungi, Parasites, and Viruses.

Based on Application, market is studied across Chemical & Material Manufacturing, Clinical, Environment, Food Testing, and Pharmaceutical. The Clinical is further studied across Bloodstream Infections, Gastrointestinal Diseases, Periodontal Diseases, Respiratory Diseases, Sexually Transmitted Diseases, and Urinary Tract Infections. The Environment is further studied across Soil Contamination Assessment and Water Quality Testing. The Food Testing is further studied across Beverages, Dairy Products, Fruits & Vegetables, Poultry & Meat, and Seafood.

Global Penetration and Regional Insights in Microbial Testing

The global reach of microbial testing mirrors the diverse demands and regulatory landscapes encountered in different regions. In the Americas, a strong emphasis on regulatory compliance and advanced diagnostic infrastructure drives market growth. This region benefits from a well-established healthcare ecosystem and a mature industrial base, where rapid diagnostic capabilities are integral to both public health and commercial productivity.

Across Europe, the Middle East, and Africa, evolving regulatory environments coupled with increasing awareness about environmental safety and food quality are fostering significant adoption of advanced microbial testing solutions. Here, the necessity to implement robust testing protocols is underscored by stringent standards imposed by governmental agencies and international bodies. The region benefits from collaborative initiatives across various sectors, leading to the integration of innovative technologies that mitigate regional challenges while promoting higher standards of operational excellence.

In the Asia-Pacific region, rapid industrialization, rising healthcare expenditures, and increased consumer awareness are the primary drivers behind the burgeoning demand for microbial testing. As economies continue to expand with a burgeoning middle class, there is an intensified focus on ensuring the safety of consumables and pharmaceuticals, as well as on maintaining quality standards in the rapidly growing food and manufacturing sectors. The region's dynamic landscape encourages the adoption of state-of-the-art testing methodologies, helping local industries synchronize with global best practices and adhere to international quality specifications.

These regional insights underscore the importance of adopting localized strategies that consider not only technological prowess but also the unique regulatory and cultural factors inherent to each market. By appreciating these nuances, industry players can tailor their approaches to maximize market penetration and drive sustainable growth across different geographies.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Driving Innovation and Market Leadership

Several industry stalwarts have been instrumental in propelling the microbial testing market forward by investing heavily in research and development, streamlining operational efficiencies, and expanding their global footprint. Prominent players such as 3M Company and Abbott Laboratories have consistently showcased innovation by integrating advanced diagnostic technologies with user-friendly platforms, ensuring both reliability and scalability in testing procedures.

Companies including Accepta Ltd. and AEMTEK Laboratories have carved out significant niches by tailoring their products to meet the exacting standards of both industrial and clinical environments. Agilent Technologies, Inc. and ALS Limited have distinguished themselves through a commitment to precision, offering comprehensive solutions that cover the entire spectrum of microbial analysis. ARL Bio Pharma, Inc. and Beckman Coulter Inc. are recognized for their contributions to advancing automated detection methods while consistently ensuring that quality is never compromised.

Key market leaders such as Becton, Dickinson and Company along with Bio-Rad Laboratories Inc. have solidified their market positions by continuously pushing the envelope in innovation and operational excellence. Other companies like bioMerieux SA, Biosan Laboratories, Inc., and Bruker Corporation have enhanced their competitive advantage by merging technological innovations with strategic regional expansions. Organizations like Charles River Laboratories and Dohler GmbH have successfully blended traditional and modern methodologies to offer robust, end-to-end testing solutions catered to diverse industry needs.

The competitive landscape is further enriched by players such as Ecolyse, Inc., Eurofins Scientific SE, and F. Hoffmann-La Roche Ltd., who have maintained leadership through their persistent focus on quality and innovation. Intertek Group PLC, LuminUltra Technologies Ltd., and Medicinal Genomics Corp. have also contributed significantly by not only adopting state-of-the-art technologies but also by embracing comprehensive quality management systems. Merck KGaA and Microbac Laboratories Inc. have been recognized for their commitment to ensuring testing accuracy, thereby reinforcing customer trust across the globe. Additional contributions from Nelson Laboratories, LLC, NEOGEN Corporation, QIAGEN N.V., Sartorius AG, SGS S.A., Shimazdu Corporation, Thermo Fisher Scientific Inc., and TUV SUD collectively illustrate a market that values interoperability, technological integration, and strategic foresight as key drivers for sustained growth.

Through their relentless pursuit of excellence, these companies have woven a narrative of innovation, resilience, and market leadership. Their endeavors not only underscore the transformative potential of microbial testing but also set the stage for future advancements that promise to redefine industry benchmarks on a global scale.

The report delves into recent significant developments in the Microbial Testing Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, Accepta Ltd., AEMTEK Laboratories, Agilent Technologies, Inc., ALS Limited, ARL Bio Pharma, Inc., Beckman Coulter Inc., Becton, Dickinson and Company, Bio-Rad Laboratories Inc., bioMerieux SA, Biosan Laboratories, Inc., Bruker Corporation, Charles River Laboratories, Dohler GmbH, Ecolyse, Inc., Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., Intertek Group PLC, LuminUltra Technologies Ltd., Medicinal Genomics Corp., Merck KGaA, Microbac Laboratories Inc., Nelson Laboratories, LLC, NEOGEN Corporation, QIAGEN N.V., Sartorius AG, SGS S.A., Shimazdu Corporation, Thermo Fisher Scientific Inc., and TUV SUD. Actionable Recommendations for Industry Leaders in Microbial Testing

For decision-makers aiming to harness the full potential of the microbial testing market, several strategic imperatives must be considered. First, it is essential to invest in advanced automation and digital technologies that can improve efficiency, reduce manual errors, and enable rapid data processing. Embracing tools like PCR and spectrometry in conjunction with traditional methods will enable faster turnaround times and more precise diagnostics. Second, it is advisable to tailor product development efforts towards addressing niche market segments. By focusing on specialized areas within the clinical, environmental, and food testing domains, companies can develop bespoke solutions that resonate with targeted consumer requirements and regulatory frameworks.

Collaboration across interdisciplinary teams that include experts in biology, engineering, and data science is another critical recommendation. Such collaborative efforts can lead to the creation of integrated platforms that merge diagnostic accuracy with real-time data analytics. This is particularly important in scenarios where timely intervention is crucial, such as in outbreak management or in environments with stringent safety standards. Furthermore, working closely with regulatory bodies and standardization organizations can help in preemptively addressing compliance challenges and in paving the way for smoother market entry.

Investments in research and development should be prioritized to continuously explore emerging technologies and improve the sensitivity and specificity of testing methods. Industry leaders are encouraged to develop strategic partnerships with academic institutions and technology firms to stay ahead of the curve on innovation trends. Additionally, adopting a customer-centric approach that involves collecting and analyzing feedback from end-users can provide valuable insights into product performance and areas for improvement.

It is also imperative to diversify geographical outreach by tailoring strategies to resonate with regional requirements. Companies should leverage localized market research to understand regional dynamics and to identify unique opportunities for growth in areas such as the Americas, Europe, Middle East and Africa, and Asia-Pacific. By aligning product portfolios with regional demands and regulatory standards, companies can ensure sustained market penetration and long-term competitiveness.

Finally, industry leaders should not underestimate the importance of robust quality control and risk management strategies. Implementing comprehensive quality management systems and regularly updating testing protocols can help in mitigating potential risks, ensuring that the highest standards are consistently met. A proactive stance on quality assurance not only builds trust with stakeholders but also reinforces the brand's reputation in the marketplace.

Conclusion: Charting the Future of Microbial Testing

The landscape of microbial testing has been irrevocably transformed by scientific innovation, evolving market requirements, and the relentless pursuit of excellence. This transformative journey has led to the integration of advanced diagnostic technologies, the refinement of testing protocols across various segments, and the adaptation of global strategies that address both regulatory and market-specific challenges. With a keen focus on automation, data integration, and specialized testing solutions, the industry stands poised to address emerging microbial threats in a landscape that is increasingly competitive and dynamic.

A comprehensive understanding of market segmentation, regional dynamics, and the competitive forces at play serves as a roadmap for stakeholders aiming to secure a competitive edge. The interplay of instruments, consumables, advanced technological applications, and diverse testing methods has laid the foundation for a future where precision, efficiency, and rapid response are paramount. This is further enriched by the evolving roles of key players who continuously drive innovation, ensuring that quality and safety are maintained even in the face of unprecedented challenges.

Looking ahead, the path forward is illuminated by opportunities for growth, collaboration, and strategic agility. By harnessing the insights derived from comprehensive market analysis, industry leaders can make informed decisions that not only meet current demands but also anticipate future trends. The continuous evolution of microbial testing is a testament to the industry's commitment to safeguarding public health, ensuring environmental sustainability, and advancing scientific innovation. As these trends converge, companies that invest in technology, innovation, and strategic global outreach will undoubtedly lead the way in transforming microbial testing into a cornerstone of modern diagnostic science.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Significant growth in biotechnology and life sciences propels the microbial testing industry
    • 5.1.1.2. Growth of the food industry necessitating microbial testing to ensure food safety
    • 5.1.1.3. Rising urbanization and industrialization contributing to the escalating demand for microbial testing
  • 5.1.2. Restraints
    • 5.1.2.1. Issues related to accuracy and subjective interpretation of test results
  • 5.1.3. Opportunities
    • 5.1.3.1. Collaboration with academic institutions and research agencies fosters advancement in microbial testing
    • 5.1.3.2. Increasing applications of AI and machine learning in enhancing microbial testing accuracy and speed in laboratories
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of standardized protocols across laboratories causing inconsistencies in testing outcomes
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Utilization of reagents & consumables for sample preparation, microbial growth, and identification processes.
  • 5.2.2. Application: Advancements in microbial food testing for detecting pathogens and safety standards
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Microbial Testing Market, by Product

• 6.1. Introduction
• 6.2. Instruments
• 6.3. Reagents & Consumables

7. Microbial Testing Market, by Technology

• 7.1. Introduction
• 7.2. Biosensors
• 7.3. Chromatography
• 7.4. Culture-Based Methods
• 7.5. Immunological Techniques
  • 7.5.1. ELISA Kits
  • 7.5.2. Lateral Flow Assays
• 7.6. Microarray Technology
• 7.7. PCR Technology
• 7.8. Spectrometry

8. Microbial Testing Market, by Organism Type

• 8.1. Introduction
• 8.2. Bacteria
• 8.3. Fungi
• 8.4. Parasites
• 8.5. Viruses

9. Microbial Testing Market, by Application

• 9.1. Introduction
• 9.2. Chemical & Material Manufacturing
• 9.3. Clinical
  • 9.3.1. Bloodstream Infections
  • 9.3.2. Gastrointestinal Diseases
  • 9.3.3. Periodontal Diseases
  • 9.3.4. Respiratory Diseases
  • 9.3.5. Sexually Transmitted Diseases
  • 9.3.6. Urinary Tract Infections
• 9.4. Environment
  • 9.4.1. Soil Contamination Assessment
  • 9.4.2. Water Quality Testing
• 9.5. Food Testing
  • 9.5.1. Beverages
  • 9.5.2. Dairy Products
  • 9.5.3. Fruits & Vegetables
  • 9.5.4. Poultry & Meat
  • 9.5.5. Seafood
• 9.6. Pharmaceutical

10. Americas Microbial Testing Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Microbial Testing Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Microbial Testing Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2024
• 13.2. FPNV Positioning Matrix, 2024
• 13.3. Competitive Scenario Analysis
  • 13.3.1. USP enhances microbiology portfolio through acquisition of Stratix Labs
  • 13.3.2. HaystackAnalytics launches comprehensive test for bacterial, fungal, and viral infections
  • 13.3.3. bioMerieux and FDA collaborate to enhance microbial detection for food safety
  • 13.3.4. Bruker Introduced New Mycobacteria and Fungi IVD Solutions for MALDI Biotyper, and a Novel LiquidArray Gastrointestinal Syndromic Panel
  • 13.3.5. Nelson Labs receives ASCA accreditation from FDA
  • 13.3.6. SGS's New Agri-Commodity and Food Testing Laboratory in Brazil Received ISO 17025 and AOAC International Accreditation
  • 13.3.7. MicroVal Approved Bio-Rad PCR Kit for Detection of STEC in Flour and Raw Dough
  • 13.3.8. Nemera and Nelson Labs Europe strengthened partnership to offer integrated services to customer
  • 13.3.9. Hardy Diagnostics Launched New Ready-To-Use Dehydrated Culture Plate
  • 13.3.10. Beckman Coulter and MeMed to Expanded Access to Proven Host Immune Response Diagnostic Able to Distinguish Between Bacterial and Viral Infections
  • 13.3.11. AstraZeneca Partnered with LBT to automate pharma microbial QC
  • 13.3.12. FASTinov collaborated with Beckman Coulter Life Sciences to bring ultra-rapid 2h-AST disruptive technology to clinical microbiology laboratories
  • 13.3.13. Thermo Fisher Scientific Inc. - Thermo Fisher Scientific Completed Acquisition of The Binding Site Group
  • 13.3.14. Roche received US FDA Emergency Use Authorization for its high-throughput automated test to detect monkeypox virus
  • 13.3.15. Charles River launched Endosafe Nexus 200
  • 13.3.16. MilliporeSigma Invested USD 286 Million in U.S. Drug Safety Testing Capacity
  • 13.3.17. Acquisition Expanded Water Microbiology Testing Capabilities Labmate Online
  • 13.3.18. ADM opened N. America microbiology lab
  • 13.3.19. SGS Acquired Industry Lab in Romania
  • 13.3.20. LuminUltra launched latest molecular diagnostic innovation with the GeneCount Corrosion Collection
  • 13.3.21. Thermo Fisher introduced new gastrointestinal bacteria detection panel
  • 13.3.22. NAMSA Acquires UK-Based Perfectus Biomed Group to Enhance Customized Microbiological Solutions
  • 13.3.23. Solvay opened a new microbiology lab for the energy sector in the UK
  • 13.3.24. Medical Genomics and UgenTec partnered to automate cannabis testing results, minimizing labor and inconsistencies
  • 13.3.25. Microgenetics developed rapid microbial test method with six-hour result time
  • 13.3.26. BD, Accelerate Diagnostics Announced Global Commercial Collaboration
  • 13.3.27. Bio-Rad buys Curiosity Diagnostics for up to USD 170 million
  • 13.3.28. bioMerieux Collaborated with FSSAI to Celebrate World Food Safety Day 2022
  • 13.3.29. PerkinElmer Expands Food Safety Testing Portfolio with AOAC Certified Microbial Count Plates
  • 13.3.30. MSU researcher received USD 769K grant to develop rapid test for foodborne pathogens - Department of Biosystems & Agricultural Engineering
  • 13.3.31. Biolog Announced New Leadership Team and Secures Major Investment to Drive Widespread Adoption of Industry-Leading Microbial Identification and Phenotypic Profiling Products
  • 13.3.32. EUR 22 million EU (USD 23.21) backing for Israeli microbiology diagnostic leader Pocared
  • 13.3.33. MilliporeSigma Launched Culture Media System For Microbiological Food Testing
  • 13.3.34. BioMerieux Acquired Antibiotic Susceptibility Test Firm Specific Diagnostics
  • 13.3.35. Thermo Fisher Scientific launched rapid environmental PCR testing solution that detects in-air SARS-CoV-2 pathogens
  • 13.3.36. BD Introduced Smart Connected Robotics to Automate Microbial Identification
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 3M Company
• 2. Abbott Laboratories
• 3. Accepta Ltd.
• 4. AEMTEK Laboratories
• 5. Agilent Technologies, Inc.
• 6. ALS Limited
• 7. ARL Bio Pharma, Inc.
• 8. Beckman Coulter Inc.
• 9. Becton, Dickinson and Company
• 10. Bio-Rad Laboratories Inc.
• 11. bioMerieux SA
• 12. Biosan Laboratories, Inc.
• 13. Bruker Corporation
• 14. Charles River Laboratories
• 15. Dohler GmbH
• 16. Ecolyse, Inc.
• 17. Eurofins Scientific SE
• 18. F. Hoffmann-La Roche Ltd.
• 19. Intertek Group PLC
• 20. LuminUltra Technologies Ltd.
• 21. Medicinal Genomics Corp.
• 22. Merck KGaA
• 23. Microbac Laboratories Inc.
• 24. Nelson Laboratories, LLC
• 25. NEOGEN Corporation
• 26. QIAGEN N.V.
• 27. Sartorius AG
• 28. SGS S.A.
• 29. Shimazdu Corporation
• 30. Thermo Fisher Scientific Inc.
• 31. TUV SUD